Skip Over Navigation Links

Members

PGRN Research Members, 2015-present

Russ B. Altman, M.D., Ph.D., Stanford University and Teri Klein, Ph.D., Pharmacogenomics Knowledge Base (PharmGKB)
Kathleen M. Giacomini, Ph.D. and Graham T. Johnson, Ph.D., University of California, San Francisco PGRN Hub
Ronald M. Krauss, M.D., Children's Hospital Oakland Research Institute, California and Aldons "Jake" Lusis, Ph.D., University of California, Los Angeles Pharmacogenomics of Statin Therapy
Mary V. Relling, Pharm.D., St. Jude Children's Research Hospital, Memphis, Tennessee and Mignon Lee-Cheun Loh, M.D., University of California, San Francisco Center for Precision Medicine in Leukemia
Mary V. Relling, Pharm.D., St. Jude Children's Research Hospital, Memphis, Tennessee and Teri E. Klein, Ph.D., Stanford University Clinical Pharmacogenetics Implementation Consortium (CPIC)
Allan Rettie, Ph.D. and Douglas M. Fowler, Ph.D., University of Washington F-CAP: Functionalization of Variants in Clinically Actionable Pharmacogenes
Dan M. Roden, M.D., Joshua C. Denny, M.D., M.S., and Elizabeth J. Phillips, M.D., Vanderbilt University Medical Center, Nashville, Tennessee Improving Prediction of Drug Action

Alumni

Christopher G. Chute, M.D., Dr. P.H.
Mayo Clinic, Rochester, Minn.
PGRN Ontology Network Resource (PHONT) Link to external Web site
David A. Flockhart, M.D., Ph.D.
Indiana University, School of Medicine
Consortium on Breast Cancer Pharmacogenomics (COBRA) Link to external Web site
Kathleen M. Giacomini, Ph.D.
University of California, San Francisco
Pharmacogenetics of Membrane Transporters (PMT) Link to external Web site
Kathleen M. Giacomini, Ph.D.
University of California, San Francisco
Pharmacogenomics Research Network III and RIKEN Center for Genomic Medicine Alliance (PGRN-CGM) Link to external Web site
Richard A. Gibbs, Ph.D.
Baylor College of Medicine, Houston
Next Gen Sequencing-Baylor/Mayo (BCM-HGSC) Link to external Web site
Julie A. Johnson, Pharm.D. and Rhonda Cooper-DeHoff, Pharm.D.
University of Florida, Gainesville
Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) Link to external Web site
John Kelsoe, M.D.
University of California, San Diego
Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD) Link to external Web site
Ronald M. Krauss, M.D.
Children's Hospital Oakland Research Institute, California
Pharmacogenomics and Risk of Cardiovascular Disease (PARC) Link to external Web site
Caryn Lerman, Ph.D., University of Pennsylvania, Philadelphia and Rachel F. Tyndale, Ph.D., University of Toronto Pharmacogenetics of Nicotine Addiction Treatment (PNAT) Link to external Web site
Julio Licinio, M.D.
University of Miami, Miller School of Medicine
University of Miami Pharmacogenetics and Pharmacogenomics Research Group (PPRG) Link to external Web site
Elaine R. Mardis, Ph.D.
The Genome Center, Washington University School of Medicine
Pharmacogenomics Research Network - Next Generation Sequencing (WU-NGS) Link to external Web site
Howard L. McLeod, Pharm.D.
University of North Carolina at Chapel Hill
Functional Polymorphism Analysis in Drug Pathways (CREATE) Link to external Web site
Prakash M. Nadkarni, M.D.
Yale University, New Haven, Connecticut
Design and Implementation of Pharmacogenetic Network (DIPN) Link to external Web site
Deborah A. Nickerson, Ph.D.
University of Washington School of Medicine, Seattle
PGRN Network Resource: Next Generation Sequencing (UW-NEXTGEN) Link to external Web site
Daniel T. O'Connor, M.D.
University of California, San Diego
Autonomic Pharmacodynamic Pharmacogenomics (APP) Link to external Wen site
Soumya Raychaudhuri, M.D., Ph.D. and Michael Brenner, M.D.
Brigham and Women's Hospital, Boston
Pharmacogenomics of Rheumatoid Arthritis Therapy (PhRAT) Link to external Web site
Mark J. Ratain, M.D., Nancy J. Cox, Ph.D. and M. Eileen Dolan, Ph.D.
University of Chicago
Pharmacogenetics of Anticancer Agents (PAAR) Link to external Web site
Mary V. Relling, Pharm.D.
St. Jude Children's Research Hospital, Memphis, Tennessee
Pharmacogenomics of Anticancer Agents Research in Children (PAAR4Kids) Link to external Web site
Marylyn D. Ritchie, Ph.D.
Vanderbilt University, Nashville, Tennessee
PGRN Statistical Analysis Resource (P-STAR) Link to external Web site
Dan M. Roden, M.D.
Vanderbilt University, Nashville, Tennessee
PharmacoGenomic discovery and replication in very large patient POPulations (PG-POP) Link to external Web site
Dan M. Roden, M.D.
Vanderbilt University Medical Center, Nashville, Tennessee
Pharmacogenomics of Arrhythmia Therapy (PAT) Link to external Web site
Mark A. Rothstein, J.D.
University of Louisville, Kentucky
Pharmacogenomics & Minority Populations (PMP) Link to external Web site
Wolfgang Sadee, Dr.rer.nat., M. Pharmacy
The Ohio State University, Columbus
Expression Genetics in Drug Therapy (XGEN) Link to external Web site
Alan R. Shuldiner, M.D.
University of Maryland School of Medicine, Baltimore
The Amish Pharmacogenomics of Anti-Platelet Intervention Study (PAPI) Link to external Web site
Kenneth E. Thummel, Ph.D. and Wylie Burke, M.D., Ph.D.
University of Washington, Seattle
Pharmacogenetics in Rural and Underserved Populations (NWAP) Link to external Web site
Richard Weinshilboum, M.D. and Liewei Wang, M.D., Ph.D.
Mayo Clinic, Rochester, Minn.
Pharmacogenetics of Phase II Drug Metabolizing Enzymes (PPII) Link to external Web site
Scott T. Weiss, M.D., M.S. and Kelan G. Tantisira, M.D., M.P.H.
Brigham and Women's Hospital and Harvard Medical School, Boston
Pharmacogenetics of Asthma Treatment (PHAT) Link to external Web site

Related Information

This page last reviewed on December 31, 2015